Skip to main content
Signal8

Viridian Therapeutics, Inc.\DE (VRDN)

Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 clinical evaluation, alongside VRDN-003, a therapeutic antibody also designed to target IGF-1R for TED. Established in 2006, this Waltham, Massachusetts-based firm previously operated as Miragen Therapeutics, Inc., before changing its name to Viridian Therapeutics, Inc. in January 2021.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

NASDAQ:VRDNHealthcare
-0.52%$24.67
AH$25.20+2.15%vs close
Mkt Cap$2.79B
Float97.43M
O/S113.29M
Vol
$ Vol
RVOL
Inst Own-
SI18.5%
Earnings
Dilution
Financials Summary
Revenue$70.85M
Net Income-$342.6M
Total Assets$899.42M
Free Cash Flow-$276.89M
Debt & Equity
Debt 6%
Equity 80%
Preferred 15%
Total Debt$50.69M
Total Equity$722.17M
Preferred Stock$132.06M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:15Reverse split
    Nov 13, 202015 shares → 1
  2. 1:15Reverse split
    Nov 7, 201615 shares → 1
Balance Sheet Details
Assets$899.42M
Liabilities$177.25M
Accounts Receivable$0
Accounts Payable$8.68M
Inventory$0
PP&E (Net)$3.65M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$70.85M$302K$314K$1.77M$2.96M$1.05M$4.46M$8.39M$4M$3.34M$2.54M$4.32M$4.32M$4.41M
YoY Growth23359.9%-3.8%-82.3%-40.2%182.2%-76.5%-46.8%109.5%20.0%31.5%-41.3%0.1%-2.0%-
Cost of Revenue$0$0$0$0$0$28.3M$0$30.42M$19.62M$2.55M$2.47M$3.24M$2.5M$3.04M
Gross Profit$70.85M$302K$314K$1.77M$2.96M-$27.25M$4.46M-$22.04M-$15.62M$789K$66K$1.08M$1.82M$1.36M
Gross Margin100.0%100.0%100.0%100.0%100.0%-2595.6%100.0%-262.8%-390.2%23.6%2.6%24.9%42.1%31.0%
Research and Development$338.93M$238.25M$159.76M$100.89M$56.89M$28.3M$34.79M$30.42M$19.62M$888K$1M$293K$97K$225K
Selling, General, and Administrative$95.31M$61.08M$95M$35.18M$25.8M$13.27M$11.65M$11.05M$10.91M$9.57M$10.25M$7.75M$2.17M$4.23M
Other$0$0$0$0$0$41.56M$0$0$0$0$0$0$0$0
Total Operating Expenses$434.24M$299.34M$254.76M$136.08M$82.69M$83.13M$46.44M$41.47M$30.54M$10.46M$11.25M$8.04M$2.26M$4.46M
Operating Income (EBIT)-$363.39M-$299.04M-$254.45M-$134.3M-$79.73M-$110.38M-$41.98M-$33.08M-$26.53M-$12.51M-$11.19M-$6.87M-$196K-$4.03M
Operating Margin-512.9%-99018.2%-81035.0%-7579.2%-2690.8%-10512.4%-941.0%-394.5%-662.8%-374.8%-440.8%-159.0%-4.5%-91.4%
Interest Expense$4.95M$3.05M$1.85M$486K$3K$508K$835K$873K$383K$95K$141K$1.02M$1.96M$1.59M
Interest Income$27.4M$32.13M$18.56M$4.92M$318K$173K$941K$1.25M$403K$0$0$0$0$0
Other Income (Expense)$20.79M$29.09M$16.72M$4.43M$315K-$335K$106K$381K$20K-$166K-$141K-$1.02M-$1.71M-$1.59M
Income Before Tax (EBT)-$342.6M-$269.95M-$237.73M-$129.87M-$79.41M-$110.72M-$41.87M-$32.7M-$26.51M-$12.67M-$11.33M-$7.89M-$2.16M-$5.62M
Income Tax Expense$0$0$0$0$0$0$0$0$95K$95K$0$0$1.96M$0
Net Income-$342.6M-$269.95M-$237.73M-$129.87M-$79.41M-$110.72M-$41.87M-$32.7M-$26.51M-$12.67M-$11.33M-$7.89M-$2.16M-$7.21M
Net Income Margin-483.6%-89387.1%-75711.5%-7329.2%-2680.2%-10544.3%-938.6%-390.0%-662.3%-379.8%-446.3%-182.6%-50.0%-163.7%
Supplementary Data
EPS-3.32-3.98-5.31-3.91-6.66-31.20-20.31-16.57-20.66-17.57-21.00-52.46-11.48-38.75
Diluted EPS-3.32-3.98-5.31-3.91-6.66-31.20-20.31-16.57-20.66-17.57-21.00-52.46-11.48-38.75
Weighted Average OS84.80M67.89M44.76M32.09M11.92M3.56M2.09M1.97M1.28M721,410539,445150,390188,115186,090
EBITDA-$337.19M-$266.36M-$235.37M-$129.13M-$79.29M-$40.28M-$40.75M-$31.55M-$25.82M-$12.24M-$11M-$6.72M-$48K-$3.88M
EBITDA Margin-475.9%-88199.7%-74957.0%-7287.4%-2676.0%-3836.2%-913.5%-376.2%-645.0%-366.7%-433.5%-155.6%-1.1%-88.1%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$212.38M$99.59M$102.83M$155.58M$42.3M$45.9M$24.85M$32.61M$47.44M$3.34M$10.83M$5.12M$209K$113K
Short-Term Investments$662.27M$617.99M$374.54M$268.97M$154.67M$81.74M$2M$29.88M$0$0$0$0$0$0
Cash and Short-Term Investments$874.65M$717.58M$477.37M$424.55M$196.97M$127.64M$26.84M$62.48M$47.44M$3.34M$10.83M$5.12M$209K$113K
Accounts Receivable$0$0$102K$102K$451K$0$108K$24K$1.46M$524K$394K$1.09M$994K$1.2M
Inventory$0$0$0-$6.62M$0$0$0$0$0$64K$187K$179K$357K$170K
Other Current Assets$19.58M$20.88M$9.01M$6.52M$100K$0-$108K$2.87M$2.97M$170K$321K$0$50K$56K
Total Current Assets$894.23M$738.46M$486.48M$424.55M$200.16M$129.61M$29.74M$65.37M$51.87M$4.26M$11.73M$6.79M$2.05M$1.66M
Long-Term Assets
Property, Plant & Equipment Net$3.65M$3.44M$3.34M$2.94M$2.06M$787K$523K$727K$563K$625K$1.15M$1.21M$928K$1.07M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.54M$501K$604K$7.61M$1.49M$857K$0$50K$50K$258K$15K$90K$690K$46K
Total Long-Term Assets$5.18M$3.94M$3.95M$10.54M$3.55M$1.64M$523K$777K$613K$883K$1.17M$1.3M$1.62M$1.12M
Other Assets$0$0$0$0$0$0$0$0$0-$883K$0$0$0$0
Total Assets$899.42M$742.4M$490.42M$435.09M$203.71M$131.25M$30.26M$66.15M$52.48M$4.26M$12.9M$8.09M$3.67M$2.78M
Liabilities
Current Liabilities
Accounts Payable$8.68M$2.14M$2.24M$14.23M$2.33M$670K$1.1M$571K$906K$159K$242K$255K$100K$27K
Short-Term Debt$0$0$0$0$0$0$3.98M$2.29M$0$0$1.1M$80K$697K$22.59M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$76K$0
Current Unearned Revenue$367K$288K$288K$288K$289K$301K$0$3.79M$0$3.38M$1.02M$0$76K$788K
Other Current Liabilities$19.66M$10.74M$12.75M$4.87M$3.75M$7.29M$674K$239K$353K$1.17M$295K$1.4M$194K$200K
Total Current Liabilities$70.7M$47.87M$26.64M$33.35M$13.64M$10.67M$10.18M$6.73M$3.9M$4.58M$2.47M$1.99M$1.39M$23.6M
Long-Term Liabilities
Long-Term Debt$49.94M$20.58M$20.2M$4.64M$0$0$4.33M$8M$9.92M$2.82M$0$0$0$42K
Long-Term Unearned Revenue$34.24M$284K$573K$861K$1.15M$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$22.37M$2.02M$989K$1.17M$688K$544K$0$66K$152K$0$24K$109K$259K$579K
Total Long-Term Liabilities$106.56M$22.89M$21.77M$6.68M$2.36M$544K$4.33M$8.07M$10.07M$2.82M$24K$109K$259K$621K
Other Liabilities$0$0$0$0$0$0$0$0$0-$2.82M$0$0$0$0
Total Liabilities$177.25M$70.76M$48.4M$40.03M$15.99M$11.22M$14.51M$14.8M$13.97M$4.58M$2.49M$2.1M$1.65M$24.22M
Stockholders' Equity
Preferred Stock$132.06M$188.88M$206.52M$142.15M$133.83M$180.8M$0$0$0$76.98M$60.85M$36.06M$0$0
Common Stock$1.02M$810K$540K$414K$239K$42K$23K$308K$226K$7K$106K$38K$28K$0
Retained Earnings-$1.34B-$995.86M-$725.91M-$488.17M-$358.3M-$278.89M-$168.17M-$126.3M-$93.59M-$30.64M-$17.97M-$6.64M-$25.89M-$21.44M
Comprehensive Income & Other$447K-$10K$338K-$390K-$157K-$8K$0-$3K-$2.83M-$0-$739K-$555K-$411K-$263K
Other Stockholders' Equity$2.06B$1.67B$1.17B$882.82M$545.78M$398.88M$183.9M$177.33M$131.88M$30.31M$28.27M$12.59M$27.89M$0
Total Equity$722.17M$671.64M$442.02M$395.06M$187.72M$120.04M$15.75M$51.34M$38.51M-$326K$10.41M$5.99M$2.03M-$21.44M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$899.42M$742.4M$490.42M$435.09M$203.71M$131.25M$30.26M$66.15M$52.48M$4.26M$12.9M$8.09M$3.67M$2.78M
Supplementary Data
Total Debt$50.69M$21.09M$21.05M$5.26M$1.04M$455K$8.3M$10.3M$9.92M$1.04M$1.1M$80K$697K$22.63M
Net Debt-$161.69M-$78.5M-$81.78M-$150.32M-$41.26M-$45.44M-$16.54M-$22.31M-$37.52M-$2.3M-$9.73M-$5.04M$488K$22.52M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$342.6M-$269.95M-$237.73M-$129.87M-$79.41M-$110.72M-$41.87M-$32.7M-$26.51M-$12.67M-$11.33M-$7.89M-$2.16M-$5.62M
Depreciation & Amortization$460K$540K$522K$255K$120K$239K$288K$281K$308K$341K$184K$144K$148K$144K
Deferred Income Tax$0$0$0$0$0$56K-$432K-$416K$0$868K$0$177K$0-$1.64M
Stock-Based Compensation$44.3M$42.15M$67.17M$19.77M$14.46M$3.65M$3.97M$3.68M$2.41M$2.11M$3.02M$4.3M$0$8K
Changes in Working Capital:
  Accounts Receivable$0$102K$0$349K-$451K$99K-$84K$1.43M-$1.44M-$130K$694K-$271K$202K-$370K
  Inventory$0$0$0$0$0$0$0-$57.8M-$50.9M$123K-$8K$178K-$187K$166K
  Accounts Payable$6.56M-$73K-$12.04M$11.52M$1.66M-$426K$525K-$335K-$101K$2.03M$633K$383K-$280K-$1.29M
  Other Working Capital$16.47M$9.57M$2.62M$4.09M$520K$4.75M$1.21M$58.64M$47.97M$161K-$220K-$185K-$384K-$110K
Total Working Capital Change$23.03M$9.6M-$9.43M$15.96M$1.72M$4.43M$1.65M$1.94M-$4.47M$2.18M$1.1M$105K-$649K-$1.61M
Other Non-Cash Items-$1.58M-$14.66M-$4.71M$54K$8.52M$72.57M$340K$376K$94K-$59K$132K$953K$1.49M$2.49M
Net Cash from Operating-$276.39M-$232.32M-$184.17M-$93.84M-$54.58M-$29.78M-$36.06M-$26.84M-$28.17M-$7.23M-$6.9M-$2.21M-$1.17M-$6.22M
Investing Activities
Capital Expenditures-$495K-$511K-$898K-$797K-$338K-$42K-$84K-$445K-$246K-$3K-$123K-$266K-$5K-$107K
Acquisitions$0$0$0$0$0$29.37M-$28.31M$0$1.28M$0$0$0$0$0
Purchases of Investments-$579.28M-$695.07M-$407.88M-$223.26M-$188.43M-$81.81M-$32.69M-$62.46M$0-$1M$0$0$0$0
Sales of Investments$542.21M$466.93M$314.53M$108.94M$114.4M$2M$61M$33M$0$1M$50K$0$0$0
Other Investing Activities$0$0$0$0$79K-$3K$28.31M-$29.46M$1.28M$0$28K-$8K$10K-$13K
Net Cash from Investing-$37.56M-$228.65M-$94.25M-$115.13M-$74.29M-$50.48M$28.23M-$29.91M$1.03M-$3K-$95K-$274K$6K-$119K
Financing Activities
Debt Repaid-$28.88M--$15M-$5M-$8.57M$2.33M--$5.33M$84K$76K-$753K-$2.04M-$6.58M
Common Stock Issuance$348.33M$453.66M$125.07M$291.87M$114.24M$25.1M$2.48M$44.53M$48.56M$0$13.1M$6.64M$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0-$173K-$363K$0-$500K$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0-$285K-$720K
Other Financing Activities$49.54M-$20.92M$9.41M-$18.63M-$5.93M-$6.22M$0-$2.61M-$1.43M$76K$50K$0-$78-$50K
Net Cash from Financing$426.74M$457.74M$225.67M$322.24M$125.28M$101.31M$70K$41.92M$52.47M-$257K$12.71M$7.4M$1.26M$5.81M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$112.79M-$3.23M-$52.75M$113.28M-$3.6M$21.05M-$7.76M-$14.84M$25.34M-$7.49M$5.71M$4.91M$97K-$539K
Supplementary Data
Operating Cash Flow-$276.39M-$232.32M-$184.17M-$93.84M-$54.58M-$29.78M-$36.06M-$26.84M-$28.17M-$7.23M-$6.9M-$2.21M-$1.17M-$6.22M
Capital Expenditure-$495K-$511K-$898K-$797K-$338K-$42K-$84K-$445K-$246K-$3K-$123K-$266K-$5K-$107K
Free Cash Flow-$276.89M-$232.83M-$185.07M-$94.64M-$54.92M-$29.82M-$36.14M-$27.29M-$28.41M-$7.23M-$7.02M-$2.48M-$1.17M-$6.33M
Cash at Beginning$99.59M$102.83M$155.58M$42.3M$45.9M$24.85M$32.61M$47.44M$22.1M$10.83M$5.12M$209K$113K$651K
Cash at End$212.38M$99.59M$102.83M$155.58M$42.3M$45.9M$24.85M$32.61M$47.44M$3.34M$10.83M$5.12M$209K$113K